PARLIAMENTARY WRITTEN QUESTION
Life Sciences: Innovation (11 December 2020)
Question Asked
To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he is taking to promote the UK as a destination for life sciences innovation, in the context of the Medicines and Healthcare products Regulatory Agency (MHRA) becoming the first regulator to approve the mRNA vaccine for covid-19 on 2 December 2020.
Asked by:
Lee Anderson (Reform UK)
Asked by:
Lee Anderson (Reform UK)
Answer
The flexibility and pragmatism of the MHRA has been instrumental to our COVID response, including enabling us to approve the COVID-19 vaccine before any other country. The MHRA will continue to pioneer innovative regulatory approaches to the most ground-breaking treatments, from the latest AI-enabled technologies to the best new precision therapies, benefiting both patients and the sector.
Answered by:
Nadhim Zahawi (Conservative)
21 December 2020
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.